13 Year IRE Patient Success StoryA case review detailing a patient that has survived for 13 years with stage 3 pancreatic cancer.
Barriers to resection following neoadjuvant chemotherapy for resectable pancreatic adenocarcinoma: A national and local perspectiveWe're thrilled to share our latest publication, delving into the Barriers to completing Neo-adjuvant Chemotherapy in earlier stage...
Optimizing Patient Selection for Irreversible Electroporation of Locally Advanced Pancreatic CancerAbstract Background: Irreversible electroporation (IRE) has emerged as a viable consolidative therapy after induction chemotherapy, in...